Liquid Tumor — Trials

Liquid Tumor — Trials · CancerIndex

Clinical trials

Registered studies

47 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05391490	Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies(KCAT19)	recruiting	Phase 1	12	University College, LondonOTHER	1	Aug 11, 2026	clinicaltrials
NCT07148180	A Multi-Site Break Through Cancer Trial: Targeting Measurable Residual Disease in Patients With Acute Myeloid Leukemia: A Phase 1/2 Study of Tagraxofusp, Azacitidine, and Venetoclax	recruiting	Phase 1 / Phase 2	31	Jacqueline Garcia, MDOTHER	1	Feb 5, 2026	clinicaltrials
NCT06119685	IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers	recruiting	Phase 1 / Phase 2	128	Indapta Therapeutics, INC.INDUSTRY	1	Jun 3, 2025	clinicaltrials

Data updated 22 days agoSource updated Aug 11, 2026source: clinicaltrials